Company profile: DNAnexus
1.1 - Company Overview
Company description
- Provider of a cloud platform and global network for scientific collaboration and accelerated discovery, delivering secure, scalable precision health data management, distribution, and analysis; bioinformatics tools and workflows; a real-world data workbench; data ingestion and metadata capture; multiomics integration; and cohort analysis and visualization.
Products and services
- Analysis Tools & Workflows: Supplies a customizable library of bioinformatics tools and enables custom analysis pipeline creation for data processing and analysis across precision health datasets within the platform
- Data Ingestion and Metadata Capture: Streamlines standardized intake and metadata capture across omics, imaging, and phenotypic datasets, harmonizing formats to enable management, distribution, and analysis within the precision health platform
- Precision Health Data Cloud: Architects a secure environment to manage, distribute, and analyze precision health datasets, supporting collaboration in a controlled setting for enterprises pursuing genomic-based approaches to accelerate discovery
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to DNAnexus
Clinical Trial Connect
HQ: United States
Website
- Description: Provider of a platform for disease foundations and advocacy groups to connect community members with relevant clinical trials. Citeline Connect accelerates clinical trial enrollment by connecting sponsors, recruitment partners, patients, healthcare providers, and sites through educational content, engagement strategies, and a globally compliant data analytics platform.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Trial Connect company profile →
Evidation
HQ: United States
Website
- Description: Provider of a platform that measures health in everyday life and enables anyone to participate in research and health programs, built on user privacy and control over permissioned health data. Through its Achievement platform, trusted by millions, it generates data with unprecedented speed, scale, and rigor to support better health outcomes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Evidation company profile →
Simulations Plus
HQ: United States
Website
- Description: Provider of ADMET and pharmacometric modeling software, including GastroPlus for absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics across administration routes in humans and animals; ADMET Predictor for compound property prediction; PKPlus for PK/TK analysis and reporting; DDDPlus for simulating in vitro dissolution to predict in vivo performance; DILIsym for drug-induced liver injury modeling; and MonolixSuite for NLME modeling.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Simulations Plus company profile →
Science 37
HQ: United States
Website
- Description: Provider of decentralized, virtual clinical trial solutions enabling universal participation by engaging patients from home. Offerings include Metasite to eliminate physical proximity barriers and allow participation from anywhere; centralized patient recruitment to confirm eligibility and consent; and remote trials connecting researchers with participants, with proven faster enrollment and higher patient retention.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Science 37 company profile →
Abbott
HQ: United States
Website
- Description: Provider of lab data management solutions, including LIMS, SDMS, and ELN, that integrate with current systems and can be rapidly configured to fit unique workflows without adding complexity or interrupting daily operations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Abbott company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for DNAnexus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to DNAnexus
2.2 - Growth funds investing in similar companies to DNAnexus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for DNAnexus
4.2 - Public trading comparable groups for DNAnexus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →